<code id='2BAA44C76B'></code><style id='2BAA44C76B'></style>
    • <acronym id='2BAA44C76B'></acronym>
      <center id='2BAA44C76B'><center id='2BAA44C76B'><tfoot id='2BAA44C76B'></tfoot></center><abbr id='2BAA44C76B'><dir id='2BAA44C76B'><tfoot id='2BAA44C76B'></tfoot><noframes id='2BAA44C76B'>

    • <optgroup id='2BAA44C76B'><strike id='2BAA44C76B'><sup id='2BAA44C76B'></sup></strike><code id='2BAA44C76B'></code></optgroup>
        1. <b id='2BAA44C76B'><label id='2BAA44C76B'><select id='2BAA44C76B'><dt id='2BAA44C76B'><span id='2BAA44C76B'></span></dt></select></label></b><u id='2BAA44C76B'></u>
          <i id='2BAA44C76B'><strike id='2BAA44C76B'><tt id='2BAA44C76B'><pre id='2BAA44C76B'></pre></tt></strike></i>

          focus

          focus

          author:fashion    Page View:48934
          House Judiciary Chairman Jerrold Nadler (D-NY) listens as Rep. Judy Chu (D-CA) speaks during a news conference.
          Reps. Jerry Nadler (D-N.Y.) and Judy Chu (D-Calif.) Joshua Roberts/Getty Images

          House Democrats are raising concerns with the Biden administration that Medicare Advantage plans need better oversight, citing recent STAT investigations that found insurance companies are using artificial intelligence and algorithmic software to deny care even when people still need it.

          On Friday, Rep. Judy Chu of California and Rep. Jerry Nadler of New York spearheaded a letter to the Centers for Medicare and Medicaid Services asking the agency to step up its oversight of Medicare Advantage insurers. Thirty other House Democrats also signed onto the letter.

          advertisement

          STAT previously reported Medicare Advantage insurers are using proprietary algorithms and AI to initiate payment denials, but that technology does not fully account for someone’s particular care needs. As a result, many frail patients have been kicked out of nursing homes, faced the prospect of draining their savings, or slogged through a long appeals process to get care they and their clinical teams think they need.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          focus

          23andMe had bad news about my health. I wish a person had delivered it
          23andMe had bad news about my health. I wish a person had delivered it

          ERICBARADAT/AFP/GettyImagesLastsummer,IthoughtitmightbefuntohavemyDNAanalyzed.Twocompanies,23andMean

          read more
          FDA approval of Sarepta Duchenne genetic therapy gives me hope
          FDA approval of Sarepta Duchenne genetic therapy gives me hope

          Duchennemusculardystrophyhistopathology.Dr.EdwinP.Ewing,Jr./CDCWhenIwasdiagnosedwithDuchennemuscular

          read more
          Anesthesiologist group: stop taking Ozempic before surgery
          Anesthesiologist group: stop taking Ozempic before surgery

          EspeciallyinthefirstweeksoftakingdrugslikeOzempic,foodstayslongerinthestomach—aprobleminsurgeries.Ad

          read more

          GSK Flovent asthma inhalers replaced by authorized generics

          AdobeAsofJan.1,thousandsofasthmapatientsintheU.S.willnolongerbeabletogetrefillsforFlovent—oneofthemo